Joseph Michael Fitzgerald - 12 Feb 2026 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP & Group Pres, Cardiology
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 12 Feb 2026
Net transactions value: -$119,481
Form type: 4
Filing time: 17 Feb 2026, 19:06:50 UTC
Previous filing: 14 Nov 2025
Next filing: 18 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	300 BOSTON SCIENTIFIC WAY, MARLBOROUGH	/s/ Susan Thompson, Attorney-in-Fact	17 Feb 2026	0001484186

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+3,462	+2.1%	$0.000000	171,504	12 Feb 2026	Direct	F1
transaction	BSX	Common Stock	Tax liability	$119,481	-1,612	-0.94%	$74.12	169,892	12 Feb 2026	Direct
holding	BSX	Common Stock						5,234	12 Feb 2026	By Child	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Restricted Stock Units	Options Exercise	$0	-3,462	-33%	$0.000000	6,924	12 Feb 2026	Common Stock	3,462		Direct	F1, F3
transaction	BSX	Restricted Stock Units	Award	$0	+18,550		$0.000000	18,550	12 Feb 2026	Common Stock	18,550		Direct	F1, F4
transaction	BSX	Stock Option (Right to Buy)	Award	$0	+43,776		$0.000000	43,776	12 Feb 2026	Common Stock	43,776	$74.12	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose.
F3	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.
F4	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.
F5	Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2027, the first anniversary of the date of grant.